Chemical Structure (Bridion 01)
Bridion Injection, Solution
Product Images NDC 0006-5423
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Bridion (NDC 0006-5423). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Merck Sharp & Dohme Llc, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Chemical Structure (Bridion 02)
Figure 1 (Bridion 03)
The text provided seems to be a table or a chart. Hence, a useful description cannot be generated from this text, and it is better to consider this as "Not Available".*
Figure 2 (Bridion 04)
Principal Display Panel (2 mL Vial Carton)
This is a description of Bridion® M, an injection used intravenously. The package contains ten 2mL vials, each with 200mg/2mL (100mg/mL) sugammadex per vial. The product is made by Merck. The text also contains an NDC code and some other hard-to-read text that is not discernable.*
Principal Display Panel (5 mL Vial Carton)
Bridion® is a non-pyrogenic solution used for intravenous injection. It contains 100mg sugammadex per mL and is adjusted to a pH of 7-8. It should be stored at 25°C with excursions permitted between 15-30°C. Each package contains ten single-dose 5mL vials and it is only for intravenous use. The usual dosage should be taken as directed in the package insert. The product is manufactured for Merck & Dohme LLC and copyrighted in 2022.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
